Member Info for Oakleaf72

Prion, imho there is a bigger play here. Many on Redditt believe the same

Good point Andy, it was an academical presentation as opposed to an RM type business one.

Just to add, can we discuss T-cell regulation? Scinv, Joey etc. Would like your thoughts and it's potential to play a part at this late stage of progression (ie, pre ITU) as we haven't talked about that much.

Scinv, maybe replication isn't the only issue at this point. Remember, the body will fight until it dies and if IFN-b keeps bolstering the immune system then maybe it can stave it off. RM's words "it seems to want to fight the virus when it's really dangerous" or words to that affect, some please quote his correct words. It's clear we don't know all the why's but we are starting to feel good about a few of the what's

Joey, isn't the mortality rate for those in ITU very high? If so, even a meagre number of 4 is something. It's not going to change anything but it is continuous info for us.

Brilliant post Joey.

Yes Meelie, Watch the first few seconds again

And that was all the way back on the 20th Feb (not today as I thought)

Surely Prion you would think so or, as said before by many is something from Activ-2 close and maybe they are holding out? That would be some RNS

It's a superb watch, yes plenty of old ground covered but talked about ITU trials, Trials in care home settings so drug can used as prophylactics, Confirmed that all HT trial data was in and referenced collecting long covid data end points, results ready in the next few weeks.

https://www.youtube.com/watch?v=qv_obkDfIaA

You can click to the time Kev it just takes a few minutes to load.

Haha Enrico, very good

If you can't see it now you never will. Thanks BR

I totally agree Doc. I am very happy.

Daplonker, an hour ago you didn't even know what was going on as you were asking for advice. Go and do some research and you might find out why.

Back to proper stuff. Doc, TL, yes all good points. With rapdily advancing techniques in mapping patients at risk from severe disease and coupled with some strong long covid data this could be more than we ever first though. This however begs the next question. Scale, we may simply not have any choice about getting a really big boat as this may have even out grown modest expectations. RM and SH can't just say no to a scenario where the world gets it much quicker. SNG is not going to sell cheap either though.

Yes but I'd rather hear SNG being mentioned than Interferon Beta. As said, here come pmjh's ducks, lining up nicely.

I remember that Fruits and yes, it's quite a thing to do, not just pinging an email

haha woody

oh scinv you are funny, in the joke sense